Streetbeat News

Revenues

TW

Tradeweb Markets Inc. reported a total trading volume of $28.9 trillion for December 2023, with an average daily volume (ADV) of $1.46 trillion.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 12:38 pm

REKR

Rekor Systems announced the expansion of its collaboration with the Texas Department of Transportation. The renewal and expansion of their partnership is valued at $2.1 million over a five-year term. This deal is expected to enhance Rekor's transportation management division by providing a steady revenue stream and strengthening its relationship with government clients.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 12:37 pm

CAG

Conagra Brands has revised its FY24 guidance, expecting a decrease in organic net sales by 1.0%-2.0%, contrasting with the prior forecast of 1% growth. The company also adjusted its EPS projection to $2.60-$2.65, down from the previous estimate of $2.70-$2.75, which is below the analyst consensus of $2.67.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 12:37 pm

CAG

Conagra Brands has revised its FY24 outlook, lowering expectations for organic net sales growth, operating margin, and adjusted EPS. The company anticipates a slower volume recovery and plans to increase investments in its brands.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 12:33 pm

AMD

CALM

INTC

MDB

MU

QQQ

SPY

WBA

U.S. stock futures are slightly higher, with investors focusing on labor market reports after hawkish Fed minutes dampened hopes for early rate cuts. Small-cap stocks and crude oil prices are in the spotlight, while bond yields have risen. Analysts from Morgan Stanley and Carson Group provided insights, suggesting no rate cuts until at least June and noting a weak Santa Claus Rally as a potential warning for market performance. In premarket trading, SPDR S&P 500 ETF Trust (SPY) and Invesco QQQ ETF (QQQ) saw slight gains, while individual stocks like AMD, INTC, CALM, MU, and MDB moved on analyst actions or company news. European stocks advanced, Asian markets declined, and cryptocurrencies traded lower.

Portfolio Pulse from Shanthi Rexaline

January 04, 2024 | 12:21 pm

AXSM

Axsome Therapeutics anticipates preliminary 4Q net product revenue of $71M, surpassing the $66.44M estimate. However, the company projects FY23 net product revenue to be $204M, which falls short of the $265.95M estimate.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 12:16 pm

KYMR

Kymera Therapeutics highlighted its immunology strategy and emerging pipeline of oral degraders targeting immuno-inflammatory diseases during its R&D Day. The company is advancing first-in-class oral degraders, including KT-621, KT-294, and KT-474 (SAR444656), which are expected to enter Phase 1 clinical trials in the second half of 2024 and first half of 2025, respectively. KT-474 is anticipated to complete enrollment in Phase 2 studies in Q4 2024, with results expected in the first half of 2025.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 12:15 pm

KRYS

The U.S. Centers for Medicare & Medicaid Services (CMS) has assigned a permanent J-code for Krystal Biotech's Vyjuvek, a treatment for Dystrophic Epidermolysis Bullosa, which will be effective from January 1, 2024. This J-code facilitates billing and reimbursement processes for Vyjuvek, potentially improving its market accessibility and adoption.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 12:12 pm

XERS

Xeris Biopharma expects its FY23 revenue to be at the high end of its previously guided range of $160M-$165M, surpassing the average analyst estimate of $161.96M. The company also anticipates becoming cash flow positive in Q4.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 12:12 pm

MRNS

Marinus Pharmaceuticals forecasts U.S. net product revenue of $32M-$34M for Ztalmy in FY24. This projection is a significant financial update for investors, indicating the company's expectations for the commercial performance of Ztalmy.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 12:09 pm